ERCC1 rs3212986 A/C polymorphism is not associated with chemotherapy treatment outcomes in gastric cancer patients: evidence from 11 publications in Chinese populations

BACKGROUND: A number of studies have investigated the roles of excision repair cross-complementation group 1 (ERCC1) gene rs3212986 polymorphisms as potential biomarkers in gastric cancer (GC). However, the results were inconsistent. Here, we performed a meta-analysis to explore ERCC1 rs3212986 poly...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Weiwei, Wang, Hanjin, Wang, Yuemei, Wang, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741989/
https://www.ncbi.nlm.nih.gov/pubmed/29302191
http://dx.doi.org/10.2147/OTT.S148214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741989/
https://www.ncbi.nlm.nih.gov/pubmed/29302191
http://dx.doi.org/10.2147/OTT.S148214

Ejemplares similares